Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Electrographic Flow Mapping Electrogram Validation in Patients With Persistent Atrial Fibrillation (FLOW EVAL-AF)

NCT06260670 is registered in ClinicalTrials.gov with Ablacon, Inc. as lead sponsor.

NCT NCT06260670
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06260670 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Electrographic Flow Mapping Electrogram Validation in Patients With Persistent Atrial Fibrillation (FLOW EVAL-AF)
Lead sponsor
Ablacon, Inc.
Phase
Not applicable
Overall status
Completed
Start date
September 1, 2022
Completion date
October 28, 2022
Enrollment
10 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

arrhythmias, cardiac, atrial fibrillation, persistent, longstanding persistent atrial fibrillation, persistent atrial fibrillation